This report contains market size and forecasts of Escitalopram in global, including the following market information:
Global Escitalopram Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Escitalopram Market Sales, 2017-2022, 2023-2028, ()
Global top five Escitalopram companies in 2021 (%)
The global Escitalopram market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Escitalopram include Lundbeck (DK), Amneal Pharmaceuticals (US), Forest Laboratories (US), TEVA (Israel), Mylan (US), Silarx Pharmacueticals (US), Apotex (CA), Lupin (IN) and Novartis (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Escitalopram manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Escitalopram Market, by Type, 2017-2022, 2023-2028 ($ Millions) & ()
Global Escitalopram Market Segment Percentages, by Type, 2021 (%)
Tablets
Solution
Global Escitalopram Market, by Application, 2017-2022, 2023-2028 ($ Millions) & ()
Global Escitalopram Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Escitalopram Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & ()
Global Escitalopram Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Escitalopram revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Escitalopram revenues share in global market, 2021 (%)
Key companies Escitalopram sales in global market, 2017-2022 (Estimated), ()
Key companies Escitalopram sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck (DK)
Amneal Pharmaceuticals (US)
Forest Laboratories (US)
TEVA (Israel)
Mylan (US)
Silarx Pharmacueticals (US)
Apotex (CA)
Lupin (IN)
Novartis (US)
Hikma Pharmaceuticals (UK)
Aurobindo Pharma (IN)
Hetero Drugs (IN)
Accord Healthcare (IN)
Macleods Pharmaceuticals (IN)
Xian Janssen Pharmaceutical (CN)
Jewim Pharmaceutical (Shandong)
Sichuan Kelun Pharmaceutical (CN)
Hunan Dongting Pharmaceutical (CN)
Zhejiang Conba Pharmaceutical (CN)
Xidian Pharmaceutical (CN)
Zhejiang Huahai Pharmaceutical (CN)